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Abstract
Long-chain polyunsaturated fatty acids (PUFAs) might regulate T-cell activation and lineage
commitment. Here, we measured the effects of omega-3 (n-3), n-6 and n-9 fatty acids on
the interaction between dendritic cells (DCs) and naïve T cells. Spleen DCs from BALB/c
mice were cultured in vitro with ovalbumin (OVA) with 50 μM fatty acids; α-linolenic acid,
arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic
acid or oleic acid and thereafter OVA-specific DO11.10 T cells were added to the cultures.
Fatty acids were taken up by the DCs, as shown by gas chromatography analysis. After cul-
ture with arachidonic acid or DHA CD11c+ CD11b+ and CD11c+ CD11bneg DCs expressed
more CD40, CD80, CD83, CD86 and PDL-1, while IAd remained unchanged. However,
fewer T cells co-cultured with these DCs proliferated (CellTrace Violetlow) and expressed
CD69 or CD25, while more were necrotic (7AAD+). We noted an increased proportion of T
cells with a regulatory T cell (Treg) phenotype, i.e., when gating on CD4+ FoxP3+ CTLA-4+,
CD4+ FoxP3+ Helios+ or CD4+ FoxP3+ PD-1+, in co-cultures with arachidonic acid- or DHA-
primed DCs relative to control cultures. The proportion of putative Tregs was inversely cor-
related to T-cell proliferation, indicating a suppressive function of these cells. With arachi-
donic acid DCs produced higher levels of prostaglandin E2 while T cells produced lower
amounts of IL-10 and IFNγ. In conclusion arachidonic acid and DHA induced up-regulation
of activation markers on DCs. However arachidonic acid- and DHA-primed DCs reduced T-
cell proliferation and increased the proportion of T cells expressing FoxP3, indicating that
these fatty acids can promote induction of regulatory T cells.
Introduction
Lymphoid organs are embedded in fat [1] and fatty acids, especially long-chain polyunsatu-
rated fatty acids (PUFAs) have immunoregulatory functions via several mechanisms. They are
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incorporated into cell membranes and affect fluidity, formation of lipid rafts and protein con-
figuration and are thereby modulating cell communication [2] but they also affect intracellular
signaling. Fatty acids diffuse through the membrane freely, or via transporters, bind to cyto-
plasmic receptors termed fatty acid binding proteins and translocate to the nucleus, where they
affect gene transcription. Lastly, some PUFAs are precursors of lipid mediators [3], which par-
ticipate in inflammatory processes and also affect acquired immune cells. For example, prosta-
glandins are potent inhibitors of T-cell proliferation [4]. The most prominent effect of PUFAs
is inhibited T-cell proliferation [5–12], particularly that of Th1 cells [13]. In general, the longer
chains and the higher degree of unsaturation, the stronger inhibitory effect [10].
Antigen presenting cells, such as dendritic cells (DCs), initiate and regulate T-cell responses.
DCs can have myeloid or lymphoid origin and these subsets differ in phenotype, localization,
and function. In mice, simplified, myeloid DCs are CD11b+ CD8- while lymphoid DCs are
CD11b- CD8+ DEC-205+ [14]. Both subsets express high levels of CD11c, MHC class II, CD86
and CD40 [15]. The heterogeneity of DCs makes it difficult to assign fixed functions to the sub-
sets [16], but in general CD11b+ DCs present MHC class II-restricted antigens to CD4+ T cells
[14], inducing a proliferative response [17]. On the contrary lymphoid CD8+ DCs induce a
limited CD4+ T cell response, associated with apoptosis [18], as well as Th1 differentiation
[19].
Presentation of antigen to naïve T cells results in activation or tolerance, depending on
interaction of MHCmolecule-TCR complex interaction, expression of costimulatory mole-
cules, cell adhesion and cytokine milieu. Mature DCs express the glycoprotein CD83, related to
the B7 ancestral family [20]. Costimulatory molecules on DCs include CD80 (B7-1) and CD86
(B7-2) that bind to CD28 on T cells, inducing T-cell activation and proliferation. However,
CD80 and CD86 can also bind to CTLA-4 (CD152) [21], which inhibits T cell IL-2 secretion
and proliferation [22]. Programmed cell death ligand 1 (PDL-1/CD274) on DCs inhibits T-cell
activation and proliferation through interaction with programmed death-1 (PD-1, PDCD1/
CD279) on T cells [23]. PD-1 is involved in regulation of peripheral tolerance and autoimmu-
nity and the PD-1: PDL pathway promotes maturation of naïve T cells into FoxP3+ CD4+ regu-
latory T cells (Tregs) [24].
Long-chain PUFAs affect cytokine secretion and expression of costimulatory molecules on
DCs [25]. In general fish oil and n-3 PUFAs reduce costimulatory molecules and antigen-pre-
sentation capacity, measured as subsequent T-cell activation [26–30]. The effects vary between
different fatty acids, also between different n-3 PUFAs [31], dose and exposure time [5] and
maturation stage of the DCs [32]. In this study, the immunoregulatory effects of fatty acids
were tested by in vitro culture of murine CD11c+ DCs with free fatty acids. We evaluated DC
phenotype, ability of fatty acid-primed DCs to activate T cells as well as subsequent T-cell
phenotype.
Material and Methods
Animals
Male BALB/c mice (Charles River, Sulzfeld, Germany) were 6–8 weeks old when used to collect
dendritic cells. Male DO11.10 H-2d [OVA T-cell receptor transgenic] BALB/c mice were the
source of OVA-specific naïve T cells. They were bred at the animal facility at the University of
Gothenburg under standard conditions. The study was carried out in accordance with recom-
mendations from the Swedish board of agriculture and approved by the regional ethical com-
mittee (Göteborgs djurförsöksetiska nämnd, permit number: 365-2011/68-2012). Mice were
sacrificed by cervical dislocation.
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Dendritic cell: T cell co-culture
The experimental design is shown in S1 Fig. Spleen DCs from mice were cultured in medium
supplemented with fatty acids, see below, and the model antigen OVA for 3 days. On day 3
DCs were analyzed by flow cytometry for cell surface molecules (CD11b, CD11c, CD40, CD83,
CD86, MHC class II IAd and PDL-1). Alternatively CellTrace™-stained OVA-specific CD4+ T
cells, isolated from DO11.10 mice, were added and co-cultured with the DCs for another 6
days. Thereafter T-cell proliferation and phenotype (expression of CD25, CD69, CTLA-4,
FoxP3, Helios and PD-1) were determined by flow cytometry.
For DCs, eight mice were sacrificed and spleens removed and prepared into single cell sus-
pension. CD11c+ cells were isolated with the MACS cell separation system (N418, Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany) and LS columns, according to the manufacturer’s
instructions. CD11c+ cells (5x104) were cultured in 96-well plates (Zellkultur Testplatte 96U,
TPP) in Iscove’s modified Dulbecco’s medium (Sigma-Aldrich Co., St Louis, MO) supple-
mented with 10% fetal bovine serum, 1% β-mercaptoethanol (4 mM solution), 1% L-glutamine
(200 mM solution, Sigma-Aldrich) and 0.1% gentamicin (50 mg/ml solution, GIBCO/Invitro-
gen, Eugene, OR). Fatty acids were dissolved in ethanol and added to DC cultures in a final
concentration of 50 μM, a physiological concentration in plasma [33, 34], within a range of
concentrations that have been used in previous in vitro experiments [5, 8, 12]. The final ethanol
concentration in the cell cultures was max 1%, when ethanol alone was used as control. The fol-
lowing fatty acids were used; 18:1 n-9 oleic acid (OA), 18:2 n-6 linoleic acid (LA), 18:3 n-3 α-
linolenic acid (ALA), 20:4 n-6 arachidonic acid (AA), 20:5 n-3 eicosapentaenoic acid (EPA)
and 22:6 n-3 DHA were used (all from Sigma-Aldrich with purity98%). Purity of stock solu-
tions was tested by gas chromatography-mass spectrometry analysis, and found to be> 90%
(S2 Fig). Stock solutions of fatty acids as well as cell culture medium were tested for presence of
staphylococcal enterotoxin with the SET-RPLA kit (Oxoid Ltd, Basingstoke, UK) and found to
be endotoxin free. OVA (grade III, Sigma-Aldrich) was added to a final concentration of
0.5 μg/μl in cell cultures later used for T-cell analysis. For blocking experiments purified anti-
mouse CD83 (HB15, clone Michel-17) or PD-1 (CD279) (clone RMP1-14) antibodies were
used in a final concentration of 10 μg/ml (both from eBioscience Inc., San Diego, CA). After 3
days the DCs were either harvested for FACS analysis of phenotype or further co-cultured with
OVA-specific T cells (5x104, giving a DC: T cell ratio of 1:1). Notably, DCs were washed and
medium renewed before co-culture with T cells to avoid direct stimulation from fatty acids on
T cells. Responder OVA-specific DO11.10 T cells were isolated and purified from spleens
using the CD4+ T cell isolation kit II (Miltenyi Biotec GmbH) according to the manufacturer’s
instructions. Isolated T cells were stained with CellTrace™ Violet (CellTrace™ Violet Cell Prolif-
eration Kit, Molecular Probes/Invitrogen) in a final concentration of 5 μM, prior to addition to
the CD11c+ cell cultures. After 6 days of co-culture T cells were harvested for flow cytometry
analysis of proliferation and phenotype.
Gas chromatography analysis of fatty acid content in dendritic cells
Cultured DCs were pooled to 4–8106 cells and washed four times with PBS. After complete
evaporation of PBS, 4 μg of an internal fatty acid standard, 17:0 in phospholipid form (Larodan
AB, Malmö, Sweden), dissolved in dichloromethane was added to the samples. Total lipids
were extracted with 5 ml 2:1 chloroform-methanol solution for 1 h. 2 ml milliQ-H2O were
added and phases separated by centrifugation. The non-polar phase was transferred to a new
tube before liquid evaporation. Fatty acids were methylated for 1 h at 75°C using 1 ml 10% ace-
tyl chloride in methanol and 1 ml toluene. 1 ml milliQ-H2O and 5 ml petroleum ether were
added. The non-polar phase was transferred to a new tube before liquid evaporation. The fatty
AA and DHA Induce DCs That Suppress T Cells
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acid methyl esters (FAME) were dissolved in 150 μl iso-octane and separated on a Agilent
Technologies 7890A GC with a 5975C MSD Triple-Axis detector (Agilent Technologies, Inc.,
Santa Clara, CA), using a VF-WAXms column (30 m x 0,25 mm, film 0,25 μm; Agilent Tech-
nologies). The fatty acids were identified with the MSD ChemStation software version
E.02.01.1177 (Agilent Technologies) and peaks identified using the GLC-463 reference stan-
dard (Nu-Chek Prep, Inc., Elysian, MN).
Flow cytometry
In brief, the procedure for flow cytometry was as follows. Cell cultures were centrifuged and
resuspended in FACS wash buffer (prepared in-house) with a 1:100 solution of Fc-receptor
block (anti-Mouse CD16/CD32 Purified, clone 93, eBioscience) and appropriate antibodies,
diluted 1:100. Samples were incubated at 4°C for 20 min and washed twice prior to flow cytom-
etry analysis. For intracellular staining of FoxP3, Helios and CTLA-4, the Foxp3/Transcription
Factor Staining Buffer Set (eBioscience) was used. The last wash was followed by addition of
permeabilization solution and samples were incubated at 4°C for 30 min. After centrifugation
and 2x wash, cells were resuspended in permeabilization buffer. Fc-receptor block and antibod-
ies (1:50) were added. After incubation, cells were washed twice in permeabilization buffer, fol-
lowed by addition of FACS wash buffer and flow cytometry analysis.
Dendritic cells were analyzed for CD11b (conjugated with PerCP-Cy5.5, clone M1/70),
CD11c (APC, clone HL3), CD80 (PE, clone 16-10A1), CD86 (Horizon V450, clone GL1),
MHC class II IAd (FITC, clone AMS-32.1) (all from BD Biosciences, San Jose, CA), CD40 (PE,
clone 3/23), CD83 (FITC, clone Michel-19) and PDL-1 (Brilliant Violet 421, clone 10F.9G2)
(all from BioLegend, San Diego, CA). T cells were analyzed for proliferation with CellTrace™
Violet or CellTrace™ CFSE stain, CD25 (PerCP-Cy5.5, clone PC61), CD69 (PerCP-Cy5.5, clone
H1.2F3), CTLA-4 (PE, clone UC10-4F10-11) (all from BD Biosciences), DO11.10 TCR (FITC,
clone KJ1-26), Helios (PerCP-Cy5.5, clone 22F6), PD-1 (APC, clone RMP1-30 (all from BioLe-
gend) as well as CD4 (FITC, clone RM4-4), FoxP3 (APC, clone FJK-16s, eBioscience). Cell via-
bility at the end of culture was analyzed with Annexin V (FITC, BioLegend) and
7-aminoactinomycin (7AAD) (BD Biosciences) in Annexin V binding buffer (BD Biosciences)
according to the manufacturer’s instructions. Cells were acquired using FACS CantoII (BD
Biosciences) and analyzed with FACSDiva (v. 6 or 8, BD Biosciences) and FlowJo (v. 7.6.5,
TreeStar Inc., Ashland, OR) software. Gating was based on “fluorescence minus one” (FMO)
samples; controls that include all of the antibody conjugates present in the test samples except
one. For each marker gates were set likewise for all samples in order to enable comparison
between samples.
Cytokines, soluble CD83 and prostaglandin E2 in cell culture
supernatant
Cytokines, IL-10, IL-12 p70, IFNγ and TGF-β1, were analyzed with DuoSet ELISA (R&D Sys-
tems, Abingdon, UK), soluble CD83 (sCD83) was analyzed with ELISA kit (Cloud-Clone
Corp., Houston, TX) and prostaglandin E2 (PGE2) was analyzed with Parameter Assay Kit
(R&D Systems) all according to instructions. A VERSAmax tunable microplate reader with the
SoftMax1 Pro 5 software (Molecular Devices Corp., Sunnyvale, CA) were used for absorbance
measurement.
Statistical analysis
Data was tested for normality with the D'Agostino & Pearson omnibus normality test.
Parametric one-way ANOVA or non-parametric Kruskal-Wallis test was used to test statistical
AA and DHA Induce DCs That Suppress T Cells
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mean difference compared to control, ethanol but no fatty acid, with correction for multiple
comparisons. For correlation analysis the parametric Pearson correlation test or the non-
parametric Spearman correlation test was used. In blocking experiments, the parametric t test
or the non-parametric MannWhiney U-test was used for comparison between blocking and
no blocking. All tests were performed two-tailed. Statistical significance levels was set at
p0.05 (), p0.01 () p0.001 () and p0.0001 (). For tests with all seven stimuli and
eight mice only p-values below 0.01 were considered statistically significant.
Results
The supplemented fatty acids were taken up by the dendritic cells
CD11c+ DCs, isolated from the spleen of BALB/c mice, were cultured for 3 days with different
fatty acids in the cell culture medium. Supplementation of arachidonic acid, DHA or oleic acid
in the culture medium was reflected in the fatty acid content of the DCs. When measured as
proportion of the cells’ total amounts of fatty acids, the levels of oleic acid increased, from
mean 12.7% to 33.2%, (p< 0.0001, Fig 1A) when added to the cell culture medium. Arachi-
donic acid changed from mean 7.0% to 8.7%, (p = 0.5253, Fig 1B) and DHA from mean 0.9%
to 2.4%, (p = 0.7716, Fig 1C) but these changes did not reach statistical significance.
No change in proportion of CD11c+CD11b+/neg DCs after fatty acid
supplementation
After 3 days of in vitro culture with fatty acids DCs were analyzed by flow cytometry for separa-
tion of DC subsets and examination of their costimulatory molecule expression (Experimental
design, S1 Fig). The FACS analysis revealed a high background in both the CD11c and CD11b
channel (Fig 2A), reflecting low purity and pronounced autofluorescence of in vitro cultured
cells. CD11c+ cells were gated, based on higher fluorescence than to the FMO control (Fig 2A)
and divided into CD11c+ CD11b+ (upper gate) and CD11c+ CD11bneg (lower gate) subpopula-
tions, shown in Fig 2A. This was made because the relative level of expression for several cell
surface molecules were higher in the CD11b+ group, as seen in the histograms in Figs 3 and 4.
The proportion of CD11c+ cells (Fig 2B) or CD11c+ CD11b+ cells (Fig 2C) did not differ
between cultures supplemented with fatty acids, compared to control cultures with ethanol
only.
Increase of costimulatory molecules on DCs after culture with
arachidonic acid or DHA
We investigated whether supplementation with fatty acids affected DC expression of MHC
class II (IAd) and costimulatory molecules, CD80, CD86 and CD40. As seen in Fig 3A, expres-
sion of MHC class II, i.e. IAd, was unaffected by fatty acids, only a non-significant reduction
was observed with arachidonic acid. Supplementation with oleic acid or α-linolenic acid
induced non-significantly higher CD80 expression (Fig 3A). In contrast, CD86 was signifi-
cantly up-regulated on CD11c+ CD11bneg DCs in response to arachidonic acid and DHA, and
also tended to increase on CD11c+ CD11b+ cells in response to DHA (Fig 3A). CD40 expres-
sion was up-regulated on CD11c+ CD11b+ in cultures with arachidonic acid or DHA, and on
CD11c+ CD11bneg DCs in cultures with DHA (Fig 3A). Representative histograms of MFI val-
ues for CD80 and CD86 are shown in Fig 3B and for CD40 and IAd in Fig 3C.
The effect of fatty acid supplementation on expression of the inhibitory molecule PDL-1
and the DC maturation marker CD83 is shown in Fig 4A. CD83 was significantly increased on
DCs cultured with arachidonic acid or DHA, which correlated with up-regulation of CD86
AA and DHA Induce DCs That Suppress T Cells
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(r = 0.9266, p< 0.0001 for CD11c+ CD11b+ DCs and r = 0.8465, p< 0.0001 for CD11c+
CD11bneg DCs, S3 Fig). Also PDL-1 was up-regulated with arachidonic acid and DHA,
although only significant for the CD11c+ CD11bneg DCs (Fig 4A). Representative histograms
of MFI values for CD83 and PDL-1 are shown in Fig 4B.
Generation of prostaglandin E2 in arachidonic acid-primed dendritic cell
cultures
We also measured soluble factors in the supernatant of DC cultures stimulated with the fatty
acids arachidonic acid, DHA or oleic acid for 72 hours. We observed high levels of PGE2,>2
pg/ml, in DC cultures stimulated with arachidonic acid whereas<0.2 pg/ml of PGE2 was
found with the other stimuli (Fig 5B). Since we observed an upregulation of CD83 expression
on DCs supplemented with arachidonic acid and DHA we also measured soluble CD83
(sCD83) in the supernatant. Only low levels of sCD83 was detected, and without differences
between the groups (Fig 5A). The levels of IL-10, IL-12 p70, and IFNγ were below detection
limit while TGF-β1 levels were in pair with the levels in fresh complete IMDM (containing
fetal bovine serum), with no differences between the groups.
In conclusion, MHC expression on DCs was unaffected by fatty acids, while arachidonic
acid and DHA up-regulated the costimulatory molecules CD40, CD83, CD86 and the inhibi-
tory molecule PDL-1. However, arachidonic acid distinguished itself from the other fatty acids
in its ability to induce PGE2 production.
Dendritic cells cultured with arachidonic acid or DHA reduced T-cell
proliferation
Next, we investigated if the fatty acid exposure of DCs would alter the outcome of the antigen-
presentation to naïve T cells. Therefore, DCs were cultured with fatty acid and the model anti-
gen OVA for 3 days, thereafter OVA-specific DO11.10+ T cells were added to the DC cultures
(S1 Fig). The gating strategy of T cells is shown in Fig 6A and 6B. Briefly, lymphocytes were
gated (upper 3 panels, Fig 6A), followed by gating for DO11.10 expression (middle panel, Fig
6A). Proliferation is shown in the lower panel of Fig 6A. After culture with OVA, about 25% of
the T cells had divided, only 2% had divided in the absence of antigen. The solvent, ethanol
Fig 1. Fatty acid uptake by dendritic cells (DCs). DC cultures were supplemented with fatty acids (50 μM); arachidonic acid (AA), docosahexaenoic acid
(DHA) or oleic acid (OA) for 3 days and thereafter the cells were analyzed by gas chromatography. The proportion of (A) oleic acid, (B) arachidonic acid and
(C) DHA of all lipid content in the cells. Black dots denote samples supplemented with fatty acid while white dots with black borders denote control (ethanol
only). Horizontal solid black lines showmedian value. The median from the control group has been extended with a dotted line for easy comparison to the
other groups. Statistical mean difference was compared to the control group. p-values: ** <0.01, *** <0.001, **** <0.0001.
doi:10.1371/journal.pone.0143741.g001
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had an inhibitory effect on proliferation, i.e. about 20% of the T cells proliferated in control cul-
tures (Fig 6A). Arachidonic acid- or DHA-primed DCs reduced subsequent T-cell prolifera-
tion, compared to the control DCs, from 20% to 5% (Fig 6C). Expression of the activation
markers CD69 and CD25 was reduced in parallel (Fig 6D and 6E). There was a correlation
between proliferation and expression of CD69 (r = 0.8587, p< 0.0001) as well as proliferation
and CD25 (r = 0.8935, p< 0.0001) (S4 Fig). None of the other investigated fatty acids (linoleic
acid, α-linolenic acid, oleic acid or EPA) suppressed the capacity to activate T cells.
Cell death in T-cell cultures with arachidonic acid- or DHA-primed
dendritic cells
We determined the levels of apoptosis and necrosis in the T cells by staining with Annexin V
and 7AAD. The gating strategy is shown in Fig 7A and 7B. Briefly, to identify debris, live cells
(Annexin V- 7AAD-) were gated and on those cells we put a non-debris gate from which CD4+
T cells were gated for Annexin V and 7AAD staining. There was a non-significantly lower pro-
portion of live T cells in the DC: T cell co-cultures with arachidonic acid-primed DCs
Fig 2. Distribution of dendritic cells (DCs) in fatty-acid supplemented cell cultures.DC cultures were supplemented with fatty acids (50 μM); α-linolenic
acid (ALA), arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA) or oleic acid (OA) for 3 days and thereafter
DCs were analyzed by flow cytometry. (A) Dot plots showing gating strategy for CD11c+ CD11bneg (lower gate) and CD11c+ CD11b+ (upper gate) DCs based
on FMO (fluorescence minus one) samples. To the right a representative sample, in the middle FMO for CD11b and to the right FMO for CD11c. (B)
Proportion of CD11c+ DCs, both CD11bneg and CD11b+, in fatty-acid supplemented cell cultures. (C) Proportion of CD11b+ cells within the CD11c+
population shown in Fig 2B. Black bars denote samples supplemented with fatty acid while white bar with black border denotes control (ethanol only). For
each group n = 8. Error bars show standard deviation.
doi:10.1371/journal.pone.0143741.g002
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Fig 3. Expression of MHC class II and costimulatory molecules on fatty-acid supplemented dendritic
cells (DCs). DC cultures were supplemented with fatty acids (50 μM); α-linolenic acid (ALA), arachidonic acid
AA and DHA Induce DCs That Suppress T Cells
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compared to control cultures (70% vs 80%, Fig 7C) and a corresponding increase in late stage
apoptotic/necrotic cells (Annexin V+ 7AAD+, 20% compared to 5%, Fig 7D), but no differ-
ences in early stage apoptotic T cells (Annexin V+ 7AAD-, Fig 7E).
Regulatory T cells in cultures with arachidonic acid- or DHA-primed
dendritic cells
Since arachidonic acid and DHA were the only fatty acids that affected DC phenotype as well
as the DCs’ ability to induce T-cell proliferation and activation markers, we chose to focus on
these and included oleic acid as an inert fatty acid control. To investigate if the low T-cell pro-
liferation observed with arachidonic acid- and DHA-primed DCs could be linked to presence
of Tregs in the cultures we stained the T cells with FoxP3, Helios, CTLA-4 and PD-1. For rep-
resentative dot plots and gating strategy see Fig 8A. We found that the proportion of FoxP3+
DO11.10+ T cells, either co-expressing Helios, CTLA-4 or PD-1 or not, were higher in DC: T
cell co-cultures in which the DCs had been primed with arachidonic acid, and to some extent
also DHA, compared to control cultures (Fig 8B). In contrast the proportion of FoxP3neg
DO11.10+ T cells co-expressing CTLA-4 or PD-1 was lower (Fig 8B). With oleic acid-primed
DCs the proportion of putative Tregs was similar as in the control cultures. If proliferation
mainly occurred among effector T cells, and not Tregs, the higher proportion of Tregs with ara-
chidonic acid and DHAmight be due to limited proliferation in these cultures and not because
of regulatory activity. Expression of Helios, CTLA-4 and PD-1 on the whole T cell population
is shown in S5 Fig.
In addition we divided the DO11.10+ T cells into FoxP3+ and FoxP3neg cells (S6A Fig) and
as stated above, there was a significantly higher proportion of FoxP3+cells with both arachi-
donic acid and DHA relative to control (S6B Fig). The FoxP3+ T cells did not differ in MFI for
FoxP3 depending on fatty acid-priming of the co-cultured DC (S6C Fig), meaning that arachi-
donic acid and DHA resulted in a higher proportion of FoxP3+ cells but not a higher expres-
sion of FoxP3 molecules on each cell. We further determined the expression of Helios, CTLA-4
and PD-1 by proportion (%) and MFI on both the FoxP3+ (S6D Fig) and FoxP3neg T-cell popu-
lation (S6E Fig). Phenotypically the FoxP3+ population were similar in all cultures i.e. the MFI
values and proportions of Helios, CTLA-4 and PD-1 were similar between the different fatty
acids and control (S6D and S6E Fig). As noted above, CTLA-4 was expressed to a lower extent
in the FoxP3neg population in both arachidonic and DHA compared to control cultures (S6E
Fig). There was a negative correlation between proliferation (% divided cells) and proportion
of Tregs assessed by the following populations; FoxP3+ Helios+ (Spearman r-value -0.92,
p<0.0001), FoxP3+ CTLA-4+ (r = - 0.94, p<0.0001) and FoxP3+ PD-1+ (r = -0.63, p = 0.0034)
(Fig 9). In summary, DCs supplemented with arachidonic acid and, to some extent, DHA
inhibit T-cell proliferation, accompanied by a higher proportion of Tregs. These Tregs have a
similar phenotype as Tregs found in oleic acid or control cultures.
(AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), oleic acid (OA) or
ethanol only (Ctrl) for 3 days and thereafter analyzed by flow cytometry. (A) Mean fluorescence intensity
(MFI) of IAd, CD80, CD86 and CD40. Left panel showMFI of CD11c+CD11bneg and right panel on
CD11c+CD11b+ DCs. Each dot represents one individual. Black dots denote samples supplemented with
fatty acid while white dots with black borders denote control (ethanol only). Horizontal solid black lines show
median value. The median from the control group has been extended with a dotted line for easy comparison
to the other groups. Statistical mean difference was compared to the control group. Data are representative of
two independent experiments. (B) Representative histograms for CD80 and CD86. (C) Representative
histograms for CD40 and IAd. In the histograms FMO samples are shown with grey color, DHA samples are
transparent with solid black border and control samples (ethanol only) are transparent with dotted black
border. p-values: ** <0.01, *** <0.001, **** <0.0001.
doi:10.1371/journal.pone.0143741.g003
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Fig 4. Expression of programmed death ligand-1 (PDL-1) and CD83 on fatty-acid supplemented
dendritic cells (DCs). DC cultures were supplemented with fatty acids (50 μM); α-linolenic acid (ALA),
arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), oleic
acid (OA) or ethanol only (Ctrl) for 3 days and thereafter analyzed by flow cytometry. (A) Mean fluorescence
intensity (MFI) of PDL-1 and CD83. Left panel showMFI of CD11c+CD11bneg and right panel of
CD11c+CD11b+ DCs. Each dot represents one individual. Black dots denote samples supplemented with
fatty acid while white dots with black borders denote control (ethanol only). Horizontal solid black lines show
median value. The median from the control group has been extended with a dotted line for easy comparison
to the other groups. Statistical mean difference was compared to the control group. Data are representative of
two independent experiments. (B) Representative histogram of each marker. In the histograms FMO samples
are shown with grey color, DHA samples are transparent with solid black border and control samples (ethanol
only) are transparent with dotted black border. p-values: ** <0.01, *** <0.001, **** <0.0001.
doi:10.1371/journal.pone.0143741.g004
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Lower levels of IL-10 and IFNγ with arachidonic acid-primed DCs in DC:
T cell co-cultures
The DC: T cell co-culture supernatant from samples with arachidonic acid-primed DCs con-
tained lower levels of IL-10 and IFNγ compared to control (Fig 10A and 10B), which supports
the low T-cell stimulatory activity with arachidonic acid. No reduction of cytokines was shown
with DHA-primed DCs, compared to controls, which suggests less T-cell suppression (Fig 10A
and 10B). IL-12 p70 was below limit of detection, TGF-β1 was in pair with the levels in fresh
complete IMDM, with no differences between the groups, while sCD83 was found in higher
levels than those found in DC culture supernatant, but still without differences between the
groups (S7 Fig).
The PD-1: PDL1 pathway is partly responsible for the low proliferation in
DC: T cell co-cultures with arachidonic acid- or DHA-primed DCs
DCs supplemented with arachidonic acid or DHA had increased expression of PDL-1 and
CD83. To evaluate if these markers were involved in the reduced T-cell activation induced by
such DCs we added either anti-CD83 or anti-PD-1 blocking antibodies to the DC: T-cell co-
Fig 5. Soluble CD83 (sCD83) and prostaglandin E2 (PGE2) in dendritic cell (DC) culture supernatant.
(A) Levels of sCD83 (pg/ml). (B) Levels of PGE2 (pg/ml). DC cultures were supplemented with fatty acids
(50 μM); arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol (Ctrl) for 3 days and
supernatants analyzed by ELISA. Black dots denote samples supplemented with fatty acid while white dots
with black borders denote control (ethanol only). Horizontal solid black lines showmedian value. The median
from the control group has been extended with a dotted line for easy comparison to the other groups.
Statistical mean difference was compared to the control group. Data are representative of one experiment.
The limit of detection (LoD) is shown with dashed black lines. p-values: * <0.05, ** <0.01, *** <0.001.
doi:10.1371/journal.pone.0143741.g005
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cultures. To achieve a more efficient blocking we blocked PD-1 instead of PDL-1, because PD-
1 can also bind another molecule, PDL-2. As demonstrated in Fig 11 blocking of PD-1 led to
increased proliferation in all DC: T-cell co-cultures. Blocking of PD-1 in arachidonic acid cul-
tures did not restore proliferation to control levels, indicating that other pathways are involved
in the low T-cell response. Blocking of CD83 led to lower proliferation in all DC: T-cell co-cul-
tures. This supports the literature describing CD83 as an activation [35] and maturation
marker [36].
The PD-1: PDL-1 pathway promotes induction of Tregs [37], so therefore we tested if PD-1
blocking changed the Treg phenotype or functionality. Indeed, the proportion of FoxP3+
Fig 6. Activation of T cells by fatty-acid supplemented dendritic cells (DCs). T cells were co-cultured for
6 days with DCs previously supplemented with fatty acids (50 μM); α-linolenic acid (ALA), arachidonic acid
(AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), oleic acid (OA) or
ethanol only (Ctrl); and thereafter analyzed by flow cytometry. (A) Gating strategy for lymphocytes (upper
row), DO11.10+ T cells (middle row) and divided DO11.10+ T cells; CellTrace™ Violetlow (bottom row). (B)
Representative dot plots showing dividing and activated (CD25+ and CD69+) DO11.10+ cells for arachidonic
acid (AA), DHA and control samples. (C) Proportion divided, (D) CD25+ and (E) CD69+ of DO11.10+ T cells.
Each dot represents one individual. Black dots denote samples supplemented with fatty acid while white dots
with black borders denote control (ethanol only). Horizontal solid black lines showmedian value. The median
from the control group has been extended with a dotted line for easy comparison to the other groups.
Statistical mean difference was compared to the control group. p-values: ** <0.01, *** <0.001, ****
<0.0001.
doi:10.1371/journal.pone.0143741.g006
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Fig 7. Viability of T cells after co-culture. T cells were analyzed with 7AAD and Annexin V after 6 days of co-culture with dendritic cells (DCs) previously
supplemented with fatty acids (50 μM); α-linolenic acid (ALA), arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic
acid (LA), oleic acid (OA) or ethanol only (Ctrl). (A) Stepwise gating procedure to eliminate debris. (B) Representative dot plots showing gating of live cells
(Annexin V- 7AAD-), apoptotic cells (Annexin V+ 7AAD-) and necrotic and late apoptotic cells (Annexin V+ 7AAD+). (C) Proportion of live, (D) necrotic and late
apoptotic and (E) apoptotic CD4+ T cells. Each dot represents one individual. Black dots denote samples supplemented with fatty acid while white dots with
black borders denote control (ethanol only). Horizontal solid black lines showmedian value. The median from the control group has been extended with a
dotted line for easy comparison to the other groups. Statistical mean difference was compared to the control group. Data are representative of two
independent experiments. p-values: ** <0.01, *** <0.001, **** <0.0001.
doi:10.1371/journal.pone.0143741.g007
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Fig 8. Co-expression of FoxP3 with Helios, CTLA-4 and PD-1. T cells were co-cultured for 6 days with dendritic cells (DCs) previously supplemented with
fatty acids (50 μM); arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only (Ctrl); and thereafter analyzed by flow cytometry. (A)
Representative dot plots from control samples showing staining of FoxP3+ and indicated markers (left column). In each plot double-positive-cells are found in
the upper right quadrant and double-negative cells in the lower left quadrant. FMO samples are shown in the right column. (B) Proportion of double-positive
(right column), FoxP3+ samples (middle column) and FoxP3- samples (left column) in CD4+ cells. Each dot represents one individual. Black dots denote
samples supplemented with fatty acid while white dots with black borders denote control (ethanol only). Horizontal black solid lines showmedian value. The
median from the control group has been extended with a dotted line for easy comparison to the other groups. Statistical mean difference was compared to the
control group. Data are representative of two independent experiments. p-values: * <0.05, ** <0.01, *** <0.001, **** <0.0001.
doi:10.1371/journal.pone.0143741.g008
Fig 9. Correlation between proliferation and expression of regulatory markers on T cells. T cells were co-cultured for 6 days with dendritic cells (DCs)
previously supplemented with fatty acids (50 μM); arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only (Ctrl); and thereafter
analyzed by flow cytometry. Proportion of divided cells was correlated to proportion of T cells double-positive for FoxP3 and (A) Helios, (B) CTLA-4, and (C)
PD-1. All samples, regardless of stimuli, were used in the same correlation analysis. The proportion of divided cells is different in (C) compared to (A) and (B)
since this staining was performed in another experiment. r value: non-parametric Spearman correlation.
doi:10.1371/journal.pone.0143741.g009
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Helios+ T cells decreased (S8A Fig) while the FoxP3+ Heliosneg population was unaffected (S8B
Fig). The putative inhibitory population of FoxP3+ CTLA-4+ T cells was unaffected as well,
with exception for the control group (S8C Fig). Hence, PD-1 blocking in fatty acid supple-
mented cultures decreased the proportion of FoxP3+ Helios+. In this experiment there was a
negative correlation between FoxP3+ Helios+ T cells and proliferation (r = -0.7161, p< 0.0001)
without blocking. With PD-1 blocking this negative correlation was increased (r = -0.7680,
p< 0.0001). Fisher r-to-z transformation revealed that this change in r-value between PD-1
blocking and no blocking was statistically non-significant (z = 0.43, p (two-tailed) = 0.6672).
Hence, with PD-1 blocking, the suppressive capacity of the FoxP3+ Helios+ T cells was unaf-
fected, but the proliferation was increased, possibly due to a lower proportion of FoxP3+
Helios+ T cells.
Fig 10. Cytokines in co-culture supernatant. Levels of (A) IL-10 and (B) IFNγ in DC: T cell co-culture
supernatants. T cells were co-cultured for 6 days with dendritic cells (DCs) previously supplemented with fatty
acids (50 μM); arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only (Ctrl).
Each dot represents one individual. Horizontal black solid lines showmedian value. The median from the
control group has been extended with a dotted line for easy comparison to the other groups. Statistical mean
difference was compared to the control group. Data are representative of two independent experiments. p-
values: * <0.05, ** <0.01, *** <0.001, **** <0.0001.
doi:10.1371/journal.pone.0143741.g010
AA and DHA Induce DCs That Suppress T Cells
PLOS ONE | DOI:10.1371/journal.pone.0143741 November 30, 2015 15 / 23
Discussion
In the present study we tested the effect of six fatty acids on expression of MHC class II and
costimulatory molecules on DCs and on the ability of the DCs to induce proliferation of naïve
T cells in the presence of antigen. Culture of DCs with the long-chain PUFAs arachidonic acid
or DHA, but no other fatty acid, led to increased expression of CD40, CD83 and CD86 as well
as PDL-1 on the DC. Strikingly, however, DCs exposed to arachidonic acid or DHA induced
lower antigen-specific T-cell proliferation and activation compared to DCs cultured in control
Fig 11. Proliferation of CD4+ T cells with and without blocking of CD83 or PD-1 during DC: T cell co-
culture. T cells were co-cultured for 6 days with DCs previously supplemented with fatty acids (50 μM);
arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only (Ctrl) without (-, No
blocking) or with 10 μg/ml purified CD83-antibody (α-CD83) or PD-1 antibody (α-PD-1); and thereafter
analyzed by flow cytometry. (A) Proportion of T cells that has proliferated (CellTrace™ CFSElow), with (+) or
without (-) PD-1 blocking. (B) Proportion of T cells that has proliferated (CellTrace™ CFSElow), with (+) or
without (-) CD83 blocking. Each dot represents one individual. Black dots denote samples supplemented with
fatty acid while white dots with black borders denote control (ethanol only). Horizontal black solid lines show
median value. Statistical mean difference, for each fatty acid or control, was compared between no blocking
and blocking. Data are representative of two experiment. p-values: * <0.05, ** <0.01, *** <0.001, ****
<0.0001.
doi:10.1371/journal.pone.0143741.g011
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medium. In parallel, a lower proportion of naïve T cells co-cultured with arachidonic acid- or
DHA-primed DCs expressed the activation markers CD25 and CD69. Thus, despite a mature
phenotype, DCs supplemented with the n-6 PUFA arachidonic acid or the n-3 PUFA DHA,
did not activate T cells.
Tregs, that express the lineage-specific transcription factor FOXP3 are known to prevent
effector T-cell proliferation [38]. Immunosuppressive effects of fatty acids mediated by induc-
tion of Tregs have been obtained by EPA supplementation during transplantation [39] and by
dietary intake of arachidonic acid and DHA, together but not one by one, in a mouse model of
dermatitis [40]. DC expression of the costimulatory molecules CD40, CD80 and CD86, has
been inversely associated with generation of FoxP3+ T cells from naïve CD4+ T cells [41] but in
our study the number of FoxP3+ Helios+ DO11.10+ T cells were higher after supplementation
with arachidonic acid or DHA to DCs, despite up-regulated activation markers. CTLA-4 is an
inhibitory molecule important for Tregs, stored intracellular, but mobilized to the surface upon
activation [42] where it binds CD80 or CD86. It has been reported as necessary for generation
of Tregs in vitro [43]. In our study CTLA-4, measured intracellular, was not up-regulated in
the T-cell cultures with suppressed proliferation. However our DC: T-cell co-culture lasted for
6 days, and Linsley et al. [44] have reported that surface expression of CTLA-4 peaks 48 h after
activation and returns to normal levels after additionally 48 hours. Altogether, if the decreased
T-cell proliferation was due to induction of Tregs, and the higher proportion of Tregs was not
the result of limited T-cell proliferation, we have shown that arachidonic acid and DHA can
induce FoxP3+ Helios+ Tregs in vitro via DCs.
PD-1: PDL-1 interaction can inhibit T-cell proliferation and activation [23, 45] and could
therefore be expected to be responsible for the T-cell unresponsiveness. Proposed mechanisms
are induction of Tregs [37]. With arachidonic acid and DHA DCs had higher PDL-1 MFI than
control DCs. However, the corresponding receptor PD-1 was not up-regulated on T cells. Our
blocking experiment showed that PD-1 blocking decreased the proportion of FoxP3+ Helios+ T
cells, which negatively correlated with increased proliferation. This effect was not limited to
any of the stimuli. The FoxP3+ Helios+ subset is generally regarded as thymus derived so we
question if these cells are generated in vitro or if they’re decreased due to higher proliferation
of effector T cells. If so, FoxP3+ Heliosneg T cells has proliferated to the same extent as FoxP3neg
T cells, since PD-1 blocking did not change the proportion of these. Expression of PD-1 has
also been associated with programmed cell death [46]. Therefore we analyzed T-cell viability
with Annexin V and 7AAD. The level of apoptotic and necrotic cells was generally low, with
reduced viability in cultures with arachidonic acid or DHA. This might be due to lack of prolif-
eration, an induction of tolerance via cell death.
CD83 was up-regulated with arachidonic acid and DHA. To our knowledge no association
between fatty acids and CD83 has been reported. The most established role for CD83 is involve-
ment in maturation of CD4+ T cells in the thymus [47]. In different setups CD83 has been
shown to support expansion of newly primed naïve CD8+ T cells [48], be required for lympho-
cyte longevity [35], enhance DCs’ stimulatory capacity [49] and thereby induce allogeneic T-cell
proliferation [50]. However, the lack of a known ligand have hampered mechanistic explanations
of CD83. CD83 expression has been correlated to expression of MHC class II [47, 51, 52] and
CD86 [47, 52]. Here, up-regulation of CD83 correlated with up-regulation of CD86, and CD83
blocking resulted in decreased proliferation, suggesting a stimulatory role for CD83. CD83 is
also found in soluble form, sCD83, formed via proteolytic cleavage of membrane-bound CD83
[53]. The extracellular soluble CD83 domain can inhibit DC-mediated T-cell proliferation [54]
as well as inhibit T-cell proliferation and production of IL-2 and IFNγ in vitro [55, 56]. We mea-
sured sCD83 but found no differences between the groups, so this could not explain the T-cell
unresponsiveness observed in cultures stimulated with arachidonic acid and DHA.
AA and DHA Induce DCs That Suppress T Cells
PLOS ONE | DOI:10.1371/journal.pone.0143741 November 30, 2015 17 / 23
Rather than having an effect on cell membrane fluidity the effects of arachidonic acid and
DHA can be caused by fatty-acid specific mechanisms. As free fatty acids, arachidonic acid and
DHA are metabolically active compounds with ability to regulate intracellular signaling path-
ways and gene transcription but also serve as precursors for lipid mediators involved in inflam-
mation. However, the suppressive effect of PUFAs can be independent of lipid mediators, as
blocking of conversion enzymes in DCs not necessarily limit suppression of T-cell activation
[25]. Because of the involvement in intracellular signaling the levels of free fatty acids are regu-
lated on several levels. Most fatty acids are esterified and bound in the membrane or in triglyc-
erides. Carrier proteins, such as fatty acid binding proteins (FABPs), can increase the solubility
and regulate the accessibility of the fatty acids to their target molecules. PUFAs can affect
expression for a plethora of genes, including the nuclear receptor peroxisome proliferator-acti-
vating receptors (PPARs) [57]. PPARγ is up-regulated in DCs upon differentiation [58] and its
expression can be induced by DHA [32]. PPARγ induction reduces DC expression of CD40,
CD80 and CD86 and capacity to activate naïve CD4+ T cells in vitro, as shown by decreased IL-
2 and IFNγ production [59].
Other studies have determined the lipid content of DCs and the association to antigen pre-
senting capacity. However the results are contradictory, DCs with high lipid content, in com-
parison to DCs with low lipid content, have been shown to be both tolerogenic [60] but also
pro-immunogenic [61]. In a study by Herber et al. MHC molecules, CD40, CD80, CD86 and
DC-SIGN were unaffected by triglyceride content while in a study by Ibrahim et al. lipid-laden
DCs had higher expression of CD1d, CD40, CD54, CD80 and CD86. Our DCs, stimulated
with arachidonic acid or DHA, displayed an activated phenotype but yet seemed to act in a
more tolerogenic fashion resulting in low T-cell responses. We did not measure total lipid con-
tent of our DCs but it might be that total fatty acid content is not the parameter that drives
DCs to become more or less tolerogenic. Instead ratios between different fatty acids or content
of individual fatty acids might be the immunomodulatory parameter. Arachidonic acid had a
stronger suppressive capacity than DHA and lowered the levels of IL-10 and IFNγ, but gave
higher DC culture supernatant levels of PGE2. Our result is in line with the notion that long-
chain PUFAs reduce T-cell proliferation, but we can show that this is true not only when the
fatty acids are added to the T cells but also when supplemented to DCs in an earlier cell culture.
The induction of FoxP3+ Tregs warrants further studies of the capability of these Tregs to sup-
press other T cells.
Supporting Information
S1 Fig. Experimental design. Dendritic cells (DCs) were isolated based on CD11c expression
and cultured in vitro with fatty acids dissolved in ethanol with or without OVA. DCs in
medium without OVA were characterized with flow cytometry at day 3 while those with OVA
were washed and thereafter co-cultured with OVA-specific T cells, stained with CellTrace™
Violet, for 6 additional days prior to flow cytometry analysis of T cells at day 9.
(TIF)
S2 Fig. Purity of fatty acids. Stock solutions of arachidonic acid (AA), docosahexaenoic acid
(DHA), oleic acid (OA) and ethanol (99% solution) were analyzed with gas chromatography,
with and without internal control. Purity is reported as area under curve of indicated fatty acid
divided with area under curve for all identified peaks. Note the difference in abundance on the
y axis for ethanol compared to the other samples.
(TIF)
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S3 Fig. The correlation between expression of CD83 and CD86 on fatty-acid supplemented
dendritic cells (DCs). DC cultures were supplemented with fatty acids (50 μM); α-linolenic
acid (ALA), arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid
(DHA), linoleic acid (LA), oleic acid (OA) or ethanol only (Ctrl) for 3 days and thereafter ana-
lyzed by flow cytometry. Proportion of DCs expressing CD83 was correlated to expression of
CD86 for (A) CD11c+CD11b+ DCs and (B) CD11c+CD11bneg DCs. All samples, regardless of
stimuli, were used in the same correlation analysis. Data was tested for normality and correla-
tion computed with Pearson correlation test.
(TIF)
S4 Fig. The correlation between proliferation and expression of CD69 and CD25. T cells for
6 days were co-cultured with dendritic cells (DCs) previously supplemented with fatty acids;
arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol (Ctrl); and
thereafter analyzed by flow cytometry. Proportion of divided cells (proliferation) was corre-
lated to expression of (A) CD69 and (B) CD25. Data was tested for normality (D'Agostino &
Pearson omnibus normality test) and correlation computed with Pearson correlation test
(CD25) or Spearman correlation test (CD69).
(TIF)
S5 Fig. Expression of Helios, CTLA-4 and PD-1. T cells were co-cultured for 6 days with den-
dritic cells (DCs) previously supplemented with fatty acids (50 μM); arachidonic acid (AA),
docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only (Ctrl); and thereafter analyzed
by flow cytometry. Expression of (A) Helios, (B) CTLA-4 and (C) PD-1. Each dot represents
one individual. Black dots denote samples supplemented with fatty acid while white dots with
black borders denote control (ethanol only). Horizontal black solid lines show median value.
The median from the control group has been extended with a dotted line for easy comparison
to the other groups. Statistical mean difference was compared to the control group. Data are
representative of two independent experiments. p-values:  <0.05,  <0.01,  <0.001, 
<0.0001.
(TIF)
S6 Fig. Phenotype of FoxP3+ and FoxP3neg T cells. T cells were co-cultured for 6 days with
dendritic cells (DCs) previously supplemented with fatty acids (50 μM); arachidonic acid (AA),
docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only (Ctrl); and thereafter analyzed
by flow cytometry. (A) Gating strategy for FoxP3+ (upper gate) and FoxP3neg (lower gate)
DO11.10+ T cells. (B) Proportion of FoxP3+ DO11.10+ T cells. (C) Mean fluorescence intensity
(MFI) of FoxP3 for the FoxP3+ T cells shown in (B). Phenotype of FoxP3+ (D) and FoxP3neg
(E) DO11.10+ T cells. For both groups proportion of CTLA-4+, Helios+ and PD-1+ cells are
shown in the left column and MFI of the same markers in the right column. Each dot repre-
sents one individual. Black dots denote samples supplemented with fatty acid while white dots
with black borders denote control (ethanol only). Horizontal solid black lines show median
value. The median from the control group has been extended with a dotted line for easy com-
parison to the other groups. Statistical mean difference was compared to the control group.
Data are representative of two independent experiments. p-values:  <0.05,  <0.01, 
<0.001,  <0.0001.
(TIF)
S7 Fig. Soluble CD83 (sCD83) in DC: T cell co-culture supernatants. T cells were co-cul-
tured with DCs previously supplemented with fatty acids; arachidonic acid (AA), docosahexae-
noic acid (DHA), oleic acid (OA) or ethanol (Ctrl); after 3 days supernatants where taken and
analyzed by ELISA. Each dot represents one individual. Horizontal black solid lines show
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median value. The median from the control group has been extended with a dotted line for
easy comparison to the other groups. Statistical mean difference was compared to the control
group. Data are representative of one experiment. The limit of detection (LoD) is shown with a
dashed black line.
(TIF)
S8 Fig. T regulatory subsets with and without blocking of PD-1 during DC: T cell co-cul-
ture. T cells were co-cultured for 6 days with DCs previously supplemented with fatty acids
(50 μM); arachidonic acid (AA), docosahexaenoic acid (DHA), oleic acid (OA) or ethanol only
(Ctrl) without (-) or with (+) 10 μg/ml purified PD-1 antibody (α-PD-1); and thereafter ana-
lyzed by flow cytometry. (A) Proportion of FoxP3+ Helios+ T cells. (B) Proportion of FoxP3+
Heliosneg T cells. (C) Proportion of FoxP3+ CTLA-4+ T cells. Each dot represents one individ-
ual. Black dots denote samples supplemented with fatty acid while white dots with black bor-
ders denote control (ethanol only). Horizontal black solid lines show median value. Statistical
mean difference, for each fatty acid or control, was compared between no blocking and block-
ing. Data are representative of one experiment. p-values:  <0.05,  <0.01,  <0.001, 
<0.0001.
(TIF)
Author Contributions
Conceived and designed the experiments: JC SÖ. Performed the experiments: JC. Analyzed the
data: JC SÖ. Contributed reagents/materials/analysis tools: AW AS. Wrote the paper: JC SÖ
AW.
References
1. Knight SC. Specialized perinodal fat fuels and fashions immunity. Immunity. 2008; 28(2):135–8. Epub
2008/02/16. doi: 10.1016/j.immuni.2008.01.003 PMID: 18275823.
2. Murphy MG. Dietary fatty acids and membrane protein function. The Journal of nutritional biochemistry.
1990; 1(2):68–79. Epub 1990/02/01. PMID: 15539188.
3. Sala-Vila A, Miles EA, Calder PC. Fatty acid composition abnormalities in atopic disease: evidence
explored and role in the disease process examined. Clinical and experimental allergy: journal of the
British Society for Allergy and Clinical Immunology. 2008; 38(9):1432–50. Epub 2008/07/31. doi: 10.
1111/j.1365-2222.2008.03072.x PMID: 18665842.
4. Shapiro AC, Wu D, Meydani SN. Eicosanoids derived from arachidonic and eicosapentaenoic acids
inhibit T cell proliferative response. Prostaglandins. 1993; 45(3):229–40. PMID: 8387219.
5. Calder PC, Bond JA, Bevan SJ, Hunt SV, Newsholme EA. Effect of fatty acids on the proliferation of
concanavalin A-stimulated rat lymph node lymphocytes. The International journal of biochemistry.
1991; 23(5–6):579–88. Epub 1991/01/01. PMID: 2065818.
6. Brouard C, Pascaud M. Modulation of rat and human lymphocyte function by n-6 and n-3 polyunsatu-
rated fatty acids and acetylsalicylic acid. Annals of nutrition & metabolism. 1993; 37(3):146–59. PMID:
8373139.
7. Jolly CA, Jiang YH, Chapkin RS, McMurray DN. Dietary (n-3) polyunsaturated fatty acids suppress
murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide.
The Journal of nutrition. 1997; 127(1):37–43. PMID: 9040541.
8. Zurier RB, Rossetti RG, Seiler CM, Laposata M. Human peripheral blood T lymphocyte proliferation
after activation of the T cell receptor: effects of unsaturated fatty acids. Prostaglandins, leukotrienes,
and essential fatty acids. 1999; 60(5–6):371–5. PMID: 10471124.
9. DeMarco DM, Santoli D, Zurier RB. Effects of fatty acids on proliferation and activation of human syno-
vial compartment lymphocytes. J Leukoc Biol. 1994; 56(5):612–5. PMID: 7964169.
10. Calder PC. Fatty-Acids, Dietary Lipids and Lymphocyte Functions. Biochemical Society transactions.
1995; 23(2):302–9. WOS:A1995RE08500020. PMID: 7672330
11. Brix S, Lund P, Kjaer TM, Straarup EM, Hellgren LI, Frøkiær H. CD4(+) T-cell activation is differentially
modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated
AA and DHA Induce DCs That Suppress T Cells
PLOS ONE | DOI:10.1371/journal.pone.0143741 November 30, 2015 20 / 23
fatty acids. Immunology. 2010; 129(3):338–50. Epub 2009/11/17. doi: 10.1111/j.1365-2567.2009.
03163.x PMID: 19909377; PubMed Central PMCID: PMC2826679.
12. Zeyda M, Szekeres AB, Säemann MD, Geyeregger R, Stockinger H, Zlabinger GJ, et al. Suppression
of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein
kinase and nuclear factor activation. Journal of immunology. 2003; 170(12):6033–9. PMID: 12794131.
13. Johansson S, Lönnqvist A, Östman S, Sandberg AS, Wold AE. Long-chain polyunsaturated fatty acids
are consumed during allergic inflammation and affect T helper type 1 (Th1)- and Th2-mediated hyper-
sensitivity differently. Clin Exp Immunol. 2010; 160(3):411–9. Epub 2010/02/13. doi: 10.1111/j.1365-
2249.2010.04107.x PMID: 20148912; PubMed Central PMCID: PMC2883112.
14. Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nature reviews
Immunology. 2013; 13(8):566–77. doi: 10.1038/nri3477 PMID: 23827956.
15. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic
cells. Annual review of immunology. 2000; 18:767–811. doi: 10.1146/annurev.immunol.18.1.767
PMID: 10837075.
16. Wu L, Dakic A. Development of dendritic cell system. Cellular & molecular immunology. 2004; 1
(2):112–8. PMID: 16212897.
17. Zarnani AH, Moazzeni SM, Shokri F, Salehnia M, Jeddi-Tehrani M. Kinetics of murine decidual den-
dritic cells. Reproduction. 2007; 133(1):275–83. doi: 10.1530/rep.1.01232 PMID: 17244753.
18. Süss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apopto-
sis. The Journal of experimental medicine. 1996; 183(4):1789–96. PMID: 8666935; PubMed Central
PMCID: PMC2192509.
19. Maldonado-López R, De Smedt T, Michel P, Godfroid J, Pajak B, Heirman C, et al. CD8alpha+ and
CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. The
Journal of experimental medicine. 1999; 189(3):587–92. PMID: 9927520; PubMed Central PMCID:
PMC2192907.
20. Berchtold S, Muhl-Zurbes P, Heufler C, Winklehner P, Schuler G, Steinkasserer A. Cloning, recombi-
nant expression and biochemical characterization of the murine CD83 molecule which is specifically
upregulated during dendritic cell maturation. FEBS letters. 1999; 461(3):211–6. PMID: 10567699.
21. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate
the suppressive function of human regulatory T cells. Journal of immunology. 2004; 172(5):2778–84.
Epub 2004/02/24. PMID: 14978077.
22. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimu-
lation. The Journal of experimental medicine. 1995; 182(2):459–65. PMID: 7543139; PubMed Central
PMCID: PMC2192127.
23. Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, et al. Interactions between PD-1 and PD-L1 pro-
mote tolerance by blocking the TCR-induced stop signal. Nature immunology. 2009; 10(11):1185–92.
doi: 10.1038/ni.1790 PMID: 19783989; PubMed Central PMCID: PMC2778301.
24. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunological
reviews. 2010; 236:219–42. doi: 10.1111/j.1600-065X.2010.00923.x PMID: 20636820; PubMed Cen-
tral PMCID: PMC2919275.
25. Zeyda M, Säemann MD, Stuhlmeier KM, Mascher DG, Nowotny PN, Zlabinger GJ, et al. Polyunsatu-
rated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. The
Journal of biological chemistry. 2005; 280(14):14293–301. doi: 10.1074/jbc.M410000200 PMID:
15684433.
26. Sanderson P, MacPherson GG, Jenkins CH, Calder PC. Dietary fish oil diminishes the antigen presen-
tation activity of rat dendritic cells. J Leukoc Biol. 1997; 62(6):771–7. PMID: 9400818.
27. Teague H, Rockett BD, Harris M, Brown DA, Shaikh SR. Dendritic cell activation, phagocytosis and
CD69 expression on cognate T cells are suppressed by n-3 long-chain polyunsaturated fatty acids.
Immunology. 2013; 139(3):386–94. doi: 10.1111/imm.12088 PMID: 23373457; PubMed Central
PMCID: PMC3701185.
28. Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty
acids reciprocally modulate dendritic cell functions mediated through TLR4. Journal of immunology.
2005; 174(9):5390–7. Epub 2005/04/22. PMID: 15843537.
29. Wang H, Hao Q, Li QR, Yan XW, Ye S, Li YS, et al. Omega-3 polyunsaturated fatty acids affect lipopoly-
saccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38. Nutri-
tion. 2007; 23(6):474–82. doi: 10.1016/j.nut.2007.04.002 PMID: 17499970.
30. KongW, Yen JH, Vassiliou E, Adhikary S, Toscano MG, Ganea D. Docosahexaenoic acid prevents
dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids in health
AA and DHA Induce DCs That Suppress T Cells
PLOS ONE | DOI:10.1371/journal.pone.0143741 November 30, 2015 21 / 23
and disease. 2010; 9:12. doi: 10.1186/1476-511X-9-12 PMID: 20122166; PubMed Central PMCID:
PMC2827414.
31. Hughes DA, Southon S, Pinder AC. (n-3) Polyunsaturated fatty acids modulate the expression of func-
tionally associated molecules on human monocytes in vitro. The Journal of nutrition. 1996; 126(3):603–
10. PMID: 8598544.
32. Zapata-Gonzalez F, Rueda F, Petriz J, Domingo P, Villarroya F, Diaz-Delfin J, et al. Human dendritic
cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR
(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J Leukoc Biol. 2008;
84(4):1172–82. doi: 10.1189/jlb.1007688 PMID: 18632990.
33. Itakura H, YokoyamaM, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al. Relationships between
plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb. 2011; 18(2):99–107.
PMID: 21099130.
34. Marangoni F, Angeli MT, Colli S, Eligini S, Tremoli E, Sirtori CR, et al. Changes of n-3 and n-6 fatty
acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA)
and 22:6 (DHA) ethyl esters and prolonged washout. Biochimica et biophysica acta. 1993; 1210(1):55–
62. PMID: 8257719.
35. Prazma CM, Yazawa N, Fujimoto Y, Fujimoto M, Tedder TF. CD83 expression is a sensitive marker of
activation required for B cell and CD4+ T cell longevity in vivo. Journal of immunology. 2007; 179
(7):4550–62. Epub 2007/09/20. PMID: 17878352.
36. LechmannM, Berchtold S, Hauber J, Steinkasserer A. CD83 on dendritic cells: more than just a marker
for maturation. Trends in immunology. 2002; 23(6):273–5. PMID: 12072358.
37. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, et al. PD-L1 regulates
the development, maintenance, and function of induced regulatory T cells. The Journal of experimental
medicine. 2009; 206(13):3015–29. doi: 10.1084/jem.20090847 PMID: 20008522; PubMed Central
PMCID: PMC2806460.
38. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nature immunology. 2007; 8
(5):457–62. doi: 10.1038/ni1455 PMID: 17440451.
39. Iwami D, Zhang Q, Aramaki O, Nonomura K, Shirasugi N, Niimi M. Purified eicosapentaenoic acid
induces prolonged survival of cardiac allografts and generates regulatory T cells. American journal of
transplantation: official journal of the American Society of Transplantation and the American Society of
Transplant Surgeons. 2009; 9(6):1294–307. doi: 10.1111/j.1600-6143.2009.02641.x PMID: 19459813.
40. Weise C, Heunemann C, Loddenkemper C, Herz U, van Tol EA, WormM. Dietary docosahexaenoic
acid in combination with arachidonic acid ameliorates allergen-induced dermatitis in mice. Pediatric
allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunol-
ogy. 2011; 22(5):497–504. Epub 2011/02/08. doi: 10.1111/j.1399-3038.2010.01133.x PMID:
21294775.
41. Wang L, Pino-Lagos K, de Vries VC, Guleria I, Sayegh MH, Noelle RJ. Programmed death 1 ligand sig-
naling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proceedings of the
National Academy of Sciences of the United States of America. 2008; 105(27):9331–6. doi: 10.1073/
pnas.0710441105 PMID: 18599457; PubMed Central PMCID: PMC2442817.
42. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, et al. A new member of the
immunoglobulin superfamily—CTLA-4. Nature. 1987; 328(6127):267–70. doi: 10.1038/328267a0
PMID: 3496540.
43. Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA. TGF-beta requires CTLA-4 early after T
cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. Journal of immu-
nology. 2006; 176(6):3321–9. PMID: 16517699.
44. Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, et al. Coexpression and func-
tional cooperation of CTLA-4 and CD28 on activated T lymphocytes. The Journal of experimental medi-
cine. 1992; 176(6):1595–604. PMID: 1334116; PubMed Central PMCID: PMC2119471.
45. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1
immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte acti-
vation. The Journal of experimental medicine. 2000; 192(7):1027–34. PMID: 11015443; PubMed Cen-
tral PMCID: PMC2193311.
46. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immuno-
globulin gene superfamily, upon programmed cell death. EMBO J. 1992; 11(11):3887–95. PMID:
1396582; PubMed Central PMCID: PMC556898.
47. Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C, et al. CD83 expression influences CD4+ T
cell development in the thymus. Cell. 2002; 108(6):755–67. PMID: 11955430.
48. Hirano N, Butler MO, Xia Z, Ansen S, von Bergwelt-Baildon MS, Neuberg D, et al. Engagement of
CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen
AA and DHA Induce DCs That Suppress T Cells
PLOS ONE | DOI:10.1371/journal.pone.0143741 November 30, 2015 22 / 23
specificity. Blood. 2006; 107(4):1528–36. doi: 10.1182/blood-2005-05-2073 PMID: 16239433; PubMed
Central PMCID: PMC1895397.
49. Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A. CD83 knockdown in monocyte-derived den-
dritic cells by small interfering RNA leads to a diminished T cell stimulation. Journal of immunology.
2007; 178(9):5454–64. PMID: 17442926.
50. Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, Bonehill A, et al. CD83 expression on
dendritic cells and T cells: correlation with effective immune responses. European journal of immunol-
ogy. 2007; 37(3):686–95. doi: 10.1002/eji.200636535 PMID: 17301951.
51. Kuwano Y, Prazma CM, Yazawa N, Watanabe R, Ishiura N, Kumanogoh A, et al. CD83 influences cell-
surface MHC class II expression on B cells and other antigen-presenting cells. International immunol-
ogy. 2007; 19(8):977–92. doi: 10.1093/intimm/dxm067 PMID: 17804692.
52. Kretschmer B, Luthje K, Guse AH, Ehrlich S, Koch-Nolte F, Haag F, et al. CD83 modulates B cell func-
tion in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. PloS one. 2007; 2(8):e755.
doi: 10.1371/journal.pone.0000755 PMID: 17710154; PubMed Central PMCID: PMC1940313.
53. Hock BD, Haring LF, Steinkasserer A, Taylor KG, PattonWN, McKenzie JL. The soluble form of CD83
is present at elevated levels in a number of hematological malignancies. Leukemia research. 2004; 28
(3):237–41. PMID: 14687618.
54. LechmannM, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, et al. The extracellular
domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic
cells. The Journal of experimental medicine. 2001; 194(12):1813–21. PMID: 11748282; PubMed Cen-
tral PMCID: PMC2193570.
55. Chen L, Zhu Y, Zhang G, Gao C, ZhongW, Zhang X. CD83-stimulated monocytes suppress T-cell
immune responses through production of prostaglandin E2. Proceedings of the National Academy of
Sciences of the United States of America. 2011; 108(46):18778–83. doi: 10.1073/pnas.1018994108
PMID: 22065790; PubMed Central PMCID: PMC3219128.
56. Cramer SO, Trumpfheller C, Mehlhoop U, More S, Fleischer B, von Bonin A. Activation-induced expres-
sion of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Interna-
tional immunology. 2000; 12(9):1347–51. PMID: 10967030.
57. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutrition reviews.
2004; 62(9):333–9. PMID: 15497766.
58. Gosset P, Charbonnier AS, Delerive P, Fontaine J, Staels B, Pestel J, et al. Peroxisome proliferator-
activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells.
European journal of immunology. 2001; 31(10):2857–65. PMID: 11592060.
59. Klotz L, Dani I, Edenhofer F, Nolden L, Evert B, Paul B, et al. Peroxisome proliferator-activated receptor
gamma control of dendritic cell function contributes to development of CD4+ T cell anergy. Journal of
immunology. 2007; 178(4):2122–31. PMID: 17277116.
60. Herber DL, CaoW, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, et al. Lipid accumulation and den-
dritic cell dysfunction in cancer. Nature medicine. 2010; 16(8):880–6. doi: 10.1038/nm.2172 PMID:
20622859; PubMed Central PMCID: PMC2917488.
61. Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS, et al. Dendritic Cell Populations With
Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver. Gastro-
enterology. 2012. Epub 2012/06/19. doi: 10.1053/j.gastro.2012.06.003 PMID: 22705178.
AA and DHA Induce DCs That Suppress T Cells
PLOS ONE | DOI:10.1371/journal.pone.0143741 November 30, 2015 23 / 23
